Genesystem Co., Ltd.

Research Genesystem Co., Ltd. (363250.KQ) on Bullrun: market cap KRW 34.35B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

Ticker363250.KQ
ExchangeKQ
CountrySouth Korea
SectorHealthcare
IndustryDiagnostics & Research
CurrencyKRW
Market capKRW 34.35B
Financial periodQ2 2026
RevenueKRW 432.34M
Net income-KRW 811.47M
Free cash flow-KRW 3.43B
Gross margin-26.2%

Valuation Snapshot

latest market cap is KRW 34.35B.

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-10-18	KRW 34.35B	n/a	n/a	n/a

Dividend history

About Genesystem Co., Ltd.

Genesystem Co., Ltd., a biotech engineering company, specializes in molecular testing solutions to target on-site testing needs. The company offers PCR systems, multiplex biochips, and PCR reagents. It also provides human pathogen assays, including novel coronavirus (SARS-CoV-2) detection kits, SARS-CoV-2/Flu/RSV simultaneous detection kits, and mycobacterium tuberculosis detection kits; veterinary diagnostics;

Related stock research

South Korea stocks South Korea Healthcare stocks A-Z stock index

Other Healthcare stocks

GeneMatrix Inc. (109820.KQ) Genoray Co., Ltd. (122310.KQ) GC Cell Corporation (144510.KQ) Optipharm.CO.,LTD (153710.KQ) Dx & Vx Co., Ltd. (180400.KQ) Cytogen, Inc. (217330.KQ) ZGOO Holdings Co., Ltd. (221800.KQ) Protia Inc. (303360.KQ) P&K Skin Research Center Co., Ltd. (347740.KQ) Noul Co.,Ltd. (376930.KQ) Coreline Soft Co., Ltd. (384470.KQ) IMB Dx, Inc. (461030.KQ)

Frequently asked questions

What is Genesystem Co., Ltd.'s market cap?

Genesystem Co., Ltd.'s market capitalization is KRW 34.35B.

What does Genesystem Co., Ltd. do?

Genesystem Co., Ltd., a biotech engineering company, specializes in molecular testing solutions to target on-site testing needs. The company offers PCR systems, multiplex biochips, and PCR reagents.